Popular Articles

Genetic Immunity, InPlay: Company To Present At Phacilitate's 8th Annual European Vaccine Forum
Power of the Dream Ventures, Inc. (OTCBB: PWRV), Hungary"s premier technology acquisition and development company, is pleased to present this Genetic Immunity release, based on a previously announced agreement whereby Power of the Dream Ventures will issue communications for Genetic Immunity on an ongoing basis.

Heart Muscle Protein Can Replace Its Missing Skeletal Muscle Counterpart To Give Mice With Myopathy A Long And Active Life
A heart muscle protein can replace its missing skeletal muscle counterpart to give mice with myopathy a long and active life, show Nowak et al. The findings were published online on May 25, 2009 (http://www.jcb.org) and will appear in the June 1, 2009 print issue of the Journal of Cell Biology.
News of the day
Use Of Lenalidomide In Patients With Multiple Myeloma Having Already Received At Least Two Previous Therapies Approved By NICE, UK
A review of the NICE decision on the approval of lenalidomide is published in a special report Online First and in the July edition of The Lancet Oncology. About 2,000 multiple myeloma sufferers in the UK could benefit from the drug and improve their life expectancy pending a decision by The UK National Institute for Health and Clinical Excellence (NICE). Patients who have received two or more previous therapies could receive lenalidomide, and the cost of cycles beyond the twenty-sixth cycle of treatment would be met by the drug manufacturer.
Nutrition

Test Detects Molecular Marker Of Aging In Humans

In 2004, researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center announced a crucial discovery in the understanding of cellular aging. They found that as cells and tissues age, the expression of a key protein, called p16INK4a, dramatically increases in most mammalian organs. Because p16INK4a is a tumor suppressor protein, cancer researchers are interested in its role in cellular aging and cancer prevention. Now the team has proven that the same biomarker is present in human blood and is strongly correlated both with chronological age and with certain behaviors such as tobacco use and physical inactivity, which are known to accelerate the aging process. In a paper published online ahead of print in the journal Aging Cell, the researchers reported that they have solved technical hurdles to develop a simple blood test to detect p16INK4a expression, which is present in cells called T lymphocytes, also known as T cells. "This is a major step toward a practical tool to clinically determine a person"s actual molecular, as opposed to just their chronological age," said UNC Lineberger member Norman Sharpless, M.D., the senior author of the study and associate professor of medicine and genetics at UNC"s School of Medicine. They validated the test by obtaining blood from two groups of healthy human volunteers, totaling 170 subjects, who also filled out a questionnaire about current and past health status and health behaviors. They found that expression of the biomarker was strongly correlated with the donor"s chronological age and, in fact, increased exponentially with age. In addition, increased levels were independently associated with tobacco use and physical inactivity as well as with biomarkers of human frailty. Sharpless said that the researchers were surprised by some of their findings, "We found a very weak correlation between the biomarker and obesity as measured by body mass index (BMI) despite other data suggesting that caloric restriction slows aging. The data suggest the possibility that reduced exercise may actually be worse with regard to molecular age than a higher BMI." "Although we don"t know whether this test is a good reflection of cellular age in all types of human tissues, we believe it is a first step toward a better understanding of issues like the suitability of organs for transplantation, how well patients are likely to recover after surgery or the future toxicity of chemotherapy for cancer patients," he added. Along with Sharpless, study co-authors from UNC Lineberger are laboratory technician Chad Torrice, postdoctoral researchers Yan Liu, Hyunsoon Cho and Christin Burd, and UNC Lineberger members Dr. Hanna Sanoff, assistant professor of medicine, Dr. Nancy Thomas, associate professor of dermatology, and Dr. Joseph Ibrahim, alumni distinguished professor of biostatistics at UNC"s Gillings School of Global Public Health. This work was supported by grants from the National Institutes of Health, the Ellison Medical Foundation and the Burroughs Wellcome Fund. University of North Carolina at Chapel Hill School of Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):